The Board of Directors of SynAct Pharma AB (publ) has announced that due to the previously announced and planned rights issue, the company has decided to advance the publication date of the interim report for the period January – March 2018 to April 19, instead of 9 May 2018 as previously communicated.
For further information about SynAct Pharma AB, please contact:
Jeppe Øvlesen Henrik Stage
CEO, SynAct Pharma AB CFO, SynAct Pharma AB
Telephone: +45 28 44 75 67 Telephone: +45 40 26 09 00
E-mail: [email protected] E-mail: hs@synactpharma.com